Eton Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	1,266	457	356	113	71	106
Market Cap Growth	206.50%	28.56%	216.20%	57.37%	-32.32%	-46.55%
Enterprise Value	1,265	462.44	370.75	96.53	61.71	97.93
Last Close Price	46.21	16.91	13.32	4.38	2.82	4.29
Forward PE	49.82	30.56	57.91	79.64	32.85	9.98
PS Ratio	14.42	5.72	9.12	3.56	3.36	4.84
PB Ratio	37.81	17.49	14.56	7.27	5.47	5.99
P/TBV Ratio	-	-	-	10.46	8.52	7.72
P/FCF Ratio	81.23	44.88	377.27	16.51	14.95	-
P/OCF Ratio	79.14	43.46	367.15	16.51	14.83	-
EV/Sales Ratio	14.55	5.78	9.50	3.05	2.90	4.49
EV/EBITDA Ratio	203.98	144.51	-	-	-	-
EV/FCF Ratio	81.98	45.38	393.16	14.16	12.90	-
Debt / Equity Ratio	1.02	1.19	1.22	0.00	0.42	0.30
Debt / EBITDA Ratio	5.03	9.69	-	-	-	-
Debt / FCF Ratio	1.97	3.04	31.73	0.79	1.36	-
Net Debt / Equity Ratio	0.38	0.19	0.61	-1.03	-0.75	-0.44
Net Debt / EBITDA Ratio	1.86	1.59	-10.32	54.94	1.51	7.47
Net Debt / FCF Ratio	0.73	0.50	15.89	-2.35	-2.04	1.63
Asset Turnover	0.92	0.95	0.72	1.11	0.81	0.81
Inventory Turnover	2.63	2.43	1.93	14.42	12.53	3.16
Quick Ratio	0.75	0.98	1.02	1.53	2.81	4.36
Current Ratio	1.21	1.57	2.06	1.65	3.10	5.18
Return on Equity (ROE)	-5.20%	-18.19%	-19.16%	-6.56%	-58.75%	-11.74%
Return on Assets (ROA)	2.13%	-1.01%	-4.83%	-5.70%	-31.47%	-5.56%
Return on Invested Capital (ROIC)	5.52%	-2.41%	-13.40%	-116.16%	-125.00%	-26.16%
Return on Capital Employed (ROCE)	3.81%	-1.54%	-7.25%	-7.00%	-39.83%	-6.58%
FCF Yield	1.23%	2.23%	0.27%	6.06%	6.69%	-
Buyback Yield / Dilution	-3.18%	-3.91%	-0.97%	-1.99%	0.24%	-19.98%
Total Shareholder Return	-3.18%	-3.91%	-0.97%	-1.99%	0.24%	-19.98%

SEC Filings: 10-K · 10-Q